Xiufen J. Liu

Xianning, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Corrigendum to "BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy" [Int. Immunopharmacol. 164 (2025) 115383].

Corrigendum to "BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy" [Int. Immunopharmacol. 164 (2025) 115383].

Journal: International immunopharmacology

Published: September 04, 2025

Schisandrin A ‌ameliorates the diabetes-associated memory impairment by alleviating inflammation and ferroptosis.

Schisandrin A ‌ameliorates the diabetes-associated memory impairment by alleviating inflammation and ferroptosis.

Journal: Acta biochimica et biophysica Sinica

Published: July 01, 2025

BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy.

BOLA3 as a key protein for the treatment of diabetic skeletal muscle atrophy.

Journal: International immunopharmacology

Published: February 04, 2025

Mesenchymal stem cell-derived exosomes in renal ischemia-reperfusion injury: a new therapeutic strategy.

Mesenchymal stem cell-derived exosomes in renal ischemia-reperfusion injury: a new therapeutic strategy.

Journal: International urology and nephrology

Published: August 20, 2024

The neuroprotective role of celastrol on hippocampus in diabetic rats by inflammation restraint, insulin signaling adjustment, Aβ reduction and synaptic plasticity alternation.

The neuroprotective role of celastrol on hippocampus in diabetic rats by inflammation restraint, insulin signaling adjustment, Aβ reduction and synaptic plasticity alternation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 09, 2024

Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.

Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.

Journal: Biology

Published: July 02, 2024

Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia.

Activation of the LKB1/AMPK/HIF-1α Pathway by Metformin to Promote Neovascularisation in Cerebral Ischaemia.

Journal: Neurochemical research

Published: April 25, 2024

Schisandrin A Alleviates Spatial Learning and Memory Impairment in Diabetic Rats by Inhibiting Inflammatory Response and Through Modulation of the PI3K/AKT Pathway.

Schisandrin A Alleviates Spatial Learning and Memory Impairment in Diabetic Rats by Inhibiting Inflammatory Response and Through Modulation of the PI3K/AKT Pathway.

Journal: Molecular neurobiology

Published: June 23, 2023

Role of transcription factor FOXM1 in diabetes and its complications (Review).

Role of transcription factor FOXM1 in diabetes and its complications (Review).

Journal: International journal of molecular medicine

Published: June 19, 2023

Drugs for treating myocardial fibrosis.

Drugs for treating myocardial fibrosis.

Journal: Frontiers in pharmacology

Published: May 13, 2023

Trelagliptin relieved cognitive impairment of diabetes mellitus rats: Involvement of PI3K/Akt/GSK-3β and inflammation pathway.

Trelagliptin relieved cognitive impairment of diabetes mellitus rats: Involvement of PI3K/Akt/GSK-3β and inflammation pathway.

Journal: Experimental gerontology

Published: March 11, 2023

Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice.

Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice.

Journal: BioFactors (Oxford, England)

Published: February 23, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026